No Image

Friday Links

October 28, 2022 AutoBot 0

Reforming the WHOs Essential Medicines List. Should countries ban dual practice by physicians? Evidence on alcohol use. College vaccine mandates and COVID deaths. Using natural […]

No Image

New tentative approval for Amneal Pharms drug saxagliptin

October 28, 2022 AutoBot 0

[![saxagliptin structure](https://www.DrugPatentWatch.com/img/drug-structure/saxagliptin.png)](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generic ingredient in one branded drug marketed by Astrazeneca Ab and is included in one NDA. There are two patents […]

No Image

New tentative approval for Teva Pharms drug eltrombopag

October 28, 2022 AutoBot 0

[![eltrombopag structure](https://www.DrugPatentWatch.com/img/drug-structure/eltrombopag.png)](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting […]

Medidata Expands Sensor Cloud Network

October 28, 2022 AutoBot 0

What You Should Know: – Medidata, a Dassault Systèmes company, and Boehringer Ingelheim, today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The […]